SlideShare a Scribd company logo
1 of 34
POST PARTUM HEMORRHAGE
By: Merga Ch. (Msc)
4/27/2024
1
Introduction
 PPH is an obstetrical emergency that can follow
vaginal or cesarean delivery.
 It is one of the top five causes of maternal
mortality in both high and low per capital
income countries
 Timely diagnosis, appropriate resources, and
appropriate management are critical for
preventing death.
Definition of PPH
1. PPH is best defined and diagnosed clinically
as excessive bleeding that makes the patient
symptomatic (e.g. lightheadedness,
weakness, palpitations, diaphoresis,
restlessness, confusion, air hunger, syncope)
and/or results in signs of hypovolemia (e.g.
hypotension, tachycardia, oliguria, low oxygen
saturation [<95%]) 4/27/2024
3
Definition …
 2) EBL ≥500 mL after vaginal birth or ≥1000 mL
after C/ delivery, or
 3) 10 % decline in postpartum Hgb concentration
from antepartum levels , or
 4) 10 % decline in postpartum maternal blood
volume from antepartum levels, and/or
 5) Need for blood transfusion following post
partum bleeding. 4/27/2024
4
Types of PPH
1) Primary PPH ( early PPH)
occurs within 24 hours after delivery
2) Secondary PPH (late PPH)
occurs 24 hours to 6 weeks after delivery
4/27/2024
5
Incidence
 The incidence of excessive blood loss following vaginal
delivery is 5–8%
 Most common cause of excessive blood loss in pregnancy
 Most transfusions in pregnant women are performed to
replace blood lost after delivery
 Leading cause of maternal death
 Every pregnant mother is at risk
4/27/2024
6
Etiology and risk factors
 Bleeding after delivery is controlled by a
combination of
1. Contraction of the myometrium, which constricts
the blood vessels supplying the placental bed,
and
2. local decidual hemostatic factors, including tissue
factor , type-1 plasminogen activator inhibitor ,
and systemic coagulation factors (eg, platelet and
circulating clotting factors).
4/27/2024
7
Etiology cont…..
The 4 Ts of PPH
 TONE 70%
 TRAUMA 20%
 TISSUE 10%
 THROMBIN 1%
3.2
4/27/2024
8
Etiology cont…..
1)Uterine Atony
 Inability of the uterine myometrium to contract
effectively.
 Is the most common cause of primary PPH
(70% )
 Complicates 1 in 20 births
4/27/2024
9
Risk factors for uterine atony
Etiology process Clinical risk factors
Over distended uterus
Polyhydramnios
Multiple gestation
Macrosomia
Uterine muscle exhaustion
Rapid or Prolonged labor
High parity
Induction/ augmentation
Intra-amniotic infection Fever
Prolonged ROM
Functional/ anatomic distortion
of the uterus
Fibroid uterus
Placenta previa
Uterine anomalies
others Drugs, GA( halothane), PA, prior
History.
4/27/2024
10
Etiology cont …..
 2) Trauma (genital tract)
 Genital tract lacerations are the second leading cause of
postpartum hemorrhage.
 Trauma related bleeding can be due to;
 Lacerations (perineal, vaginal, cervical, uterine),
 Incisions ( hysterotomy , episiotomy),
Uterine rupture, or
Uterine inversion.
Risk factors for Genital tract laceration????:
4/27/2024
11
Etiology cont…..
 3) RPOC( placental tissue and amniotic membranes) can
inhibit the uterus from adequate contraction and result in
hemorrhage
 Risk factors include:
 Midtrimester delivery
 Chorioamnionitis
 Accessory placental lobes
 Abnormally adherent placenta
 Accreta ….80%
 Increta …...15%
 Percreta ………..5%
• Retained blood clots
• Mismanagement of third stage of labor
4/27/2024
12
Etiology cont…..
4) Coagulation defects
 Acquired and congenital bleeding.
 Pre-existing states resulting in coagulation defects includes:
 hemophilia A
 Acquired causes of coagulopathy include ;
 severe preeclampsia and eclampsia,
 HELLP syndrome,
 Abruption placentae,
 Fetal demise (IUFD),
 Amniotic fluid embolism (AFE),
 Sepsis,
 Transfusion of more than 8 U of blood in itself may induce a
dilutional coagulopathy.
 Consumptive coagulopathy may develop in women with
severe hemorrhage.
4/27/2024
13
Complications of PPH
 Hypovolemic shock and organ failure:
 renal failure, stroke, myocardial infarction,
 Postpartum hypopituitarism (Sheehan syndrome)
 Fluid overload (pulmonary edema, dilutional coagulopathy)
 Anemia
 Transfusion-related complications
 Anesthesia-related complications
 Sepsis, wound infection, pneumonia
 Venous thrombosis or embolism
 Unplanned sterilization due to need for hysterectomy
 Asherman syndrome
 Death
4/27/2024
14
Prevention of PPH
 Identify high risk factors for PPH & do proper investigation and
preparation,
 Iron supplementation during px to build up iron store in high
risk women,
 Seek and treat anemia in pregnancy
 Family planning/child spacing
 AMTSL for all delivering mothers.
 Spontaneous placental separation during cesarean delivery, and
 Prolonged postpartum oxytocin infusion.
4/27/2024
15
Prevention cont…
 AMTSL- for all laboring mothers
 Active management of the third stage of labour prevents
PPH by over 60%
 Components of AMTSL are;
1. administering uterotonic agent, oxytocin 10 IU IM with
in 1 min after delivery
2. Controlled cord traction (CCT),
3. Uterine massage and.
4. Early cord clamping
4/27/2024
16
Uterotonic Selection for Prevention of PPH
Uterotonic Advantages/Disadvantag
es
Doses for
Preventio
n
Storage
Requirements
Oxytocin
(IM
injection)
• Effective 2-3 minutes
after injection.
• Can only be given
intramuscularly.
• Can be used in all
women.
• Reduces length of
third stage of labor.
• Used ONLY after the
delivery of the baby.
• Minimal side effects.
• Inexpensive.
10 IU • Store between
15C & 25C (59-
77 F).
• Delivery room
stock may be
kept at room
temperature—
30C—for up to
one year with an
expected loss of
about 14
percent.
• Light does not
destabilize
oxytocin.
3.3
4/27/2024
17
Uterotonic Selection for Prevention of PPH
Uterotonic Advantages/Disadvantages Doses for
Prevention
Storage
Requirements
Ergometrine
(IM Injection)
• Effective 6-7 minutes after
injection.
• Effects may last 2-4 hours.
• Inexpensive.
• Contraindicated in women
with PE, Eclampsia, and
high BP.
• Can cause nausea and
vomiting.
• Requires stringent
handling and storage
conditions.
0.2mg-0.4mg
(use local
standards as
dosage may
range from 0.2
mg – 4 mg)
• Store between 2°C
– 8°C.
• Protect from light
and freezing.
• Requires stringent
handling and
storage conditions.
3.4
4/27/2024
18
Uterotonic Selection for Prevention of PPH
Uterotonic Advantages/Disadvantage
s
Doses for
Prevention
Storage
Requirements
Misoprostol
(tablet)
• Effective 9-12 minutes
after ingestion.
• Shivering, nausea and
elevated temperature.
Oral or SL: 600µg
Rectal: 800-
1000µg
• Store at room
temperature in a
closed container.
3.5
4/27/2024
19
MANAGEMENT
Multidisciplinary approach:-
Clinicians, OBGYN, Anesthetist, Hematologist, Nurse/Midwives,
Laboratory tech… etc
4/27/2024
20
Management of PPH
4/27/2024
21
 Early recognition of PPH is a very important
factor in mgt.
 An established plan of action for the
management of PPH is of great value when
the preventative measures have failed.
 Treatment goals
 Restore or maintain adequate circulatory
volume to prevent hypo perfusion of vital
organs
 Restore or maintain adequate tissue
oxygenation
 Reverse or prevent coagulopathy
 Eliminate the obstetric cause of PPH
GENEERAL MEASURES
 SHOUT FOR HELP!!!!!! (Get assistance)
 ABCs of life
 Oxygenate (intranasal)
 Open 2 IV lines (large bore cannula) and resuscitate
with crystalloids fast to restore circulatory volume.
 Send blood sample to laboratory
 Massage uterus and Give oxytocin 10 IU IM
 Catheterize and monitor UOP
 Evaluate the possible cause of the PPH
4/27/2024
22
4/27/2024
23
Uterine massage
uterotonic
drugs
Bimanual compression and
massage
Uterine balloon
tamponade
Surgical
management
If no response
If no response
If no response
If no response
Specific Management : for uterine
atony
Specific measures…Uterine Atony
 Remove clots
 Avoid distended bladder
 Medical therapy
 Oxytocin 20 units in 1000 ml 0f NS Or RL 60
drops/min (>125ml/hr) IV (not more than 3 lit.)
 Misoprostol 800-1000 μg PR, SL route allows for
lower dosing (400 μg) with higher bioavailability
 Methylergometrine 0.2mg can be repeated every 2-4 hr
IM or IV ergometrine (maximum 5 doses)
4/27/2024
24
Options if medical treatment fails for uterine atony
 If bleeding continues:
 Explore the uterine cavity
 Check placenta again for completeness
 Inspect the cervix and the lower genitalia for laceration
 If bleeding continues in spite of the above:
 Perform bimanual compression of the uterus or compress
abdominal aorta until surgical intervention is amenable.
4/27/2024
25
Bimanual and Aorta compression
4/27/2024
26
Uterine Tamponade
4/27/2024
27
 Uterine packing
 Transurethral Foley
catheter placement and
prophylactic antibiotic
 A tamponade-balloon
 Inserted into the uterus
and inflated with 500ml
of saline
Management cont…
 Surgical option include:
 B Lynch surgery
 Uterine artery ligation
 Uterine compression sutures
 Hysterectomy
4/27/2024
28
B-Lynch suturing
4/27/2024
29
Uterine & utero-ovarian
artery ligation
4/27/2024
30
Management cont…
2) Genital tract laceration
-Repair of the tear/laceration
-hysterectomy
4/27/2024
31
Management cont…
3) RPC
 Retained Products of
Conceptions
 Different methods of removal
of RPCs.
 Manual removal
 Uterine Curettage
 Hysterectomy
4/27/2024
32
Management cont…
4) Coagulation defects
 Lab investigations: platelet count, PT, PTT, fibrinogen level,
clotting time
 Treatment
 Use blood products to control hemorrhage
 Give fresh whole blood if available.
 Otherwise choose fresh frozen plasma, packed RBC,
cryoprecipitate or platelet concetrate based on the major disorder
recognized
4/27/2024
33
THANK YOU ! 4/27/2024
34

More Related Content

Similar to 1.post portum heamorrghage power pont.pptx

Postpartum hemorrhge final دراسات عليا.pptx
Postpartum hemorrhge final دراسات عليا.pptxPostpartum hemorrhge final دراسات عليا.pptx
Postpartum hemorrhge final دراسات عليا.pptx
abdelnaser5
 
Primary Postpartum Haemorrhage
Primary Postpartum HaemorrhagePrimary Postpartum Haemorrhage
Primary Postpartum Haemorrhage
Victor Ordu
 
Anaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageAnaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhage
Sasidhar Puvvula
 

Similar to 1.post portum heamorrghage power pont.pptx (20)

Postpartum hemorrhge final دراسات عليا.pptx
Postpartum hemorrhge final دراسات عليا.pptxPostpartum hemorrhge final دراسات عليا.pptx
Postpartum hemorrhge final دراسات عليا.pptx
 
OBSTETRIC HAEMORRHAGE.pptx
OBSTETRIC HAEMORRHAGE.pptxOBSTETRIC HAEMORRHAGE.pptx
OBSTETRIC HAEMORRHAGE.pptx
 
Complications of peuperium
Complications of peuperiumComplications of peuperium
Complications of peuperium
 
pph.pptx
pph.pptxpph.pptx
pph.pptx
 
POSTPARTUM HAEMORRHAGE.pptx
POSTPARTUM HAEMORRHAGE.pptxPOSTPARTUM HAEMORRHAGE.pptx
POSTPARTUM HAEMORRHAGE.pptx
 
TJ MASHAMBA.ppt
TJ MASHAMBA.pptTJ MASHAMBA.ppt
TJ MASHAMBA.ppt
 
PPH.pdf
PPH.pdfPPH.pdf
PPH.pdf
 
Post Partum Hemorrhage (PPH).ppt
Post Partum Hemorrhage (PPH).pptPost Partum Hemorrhage (PPH).ppt
Post Partum Hemorrhage (PPH).ppt
 
Primary postpartum haemorrage
Primary postpartum haemorragePrimary postpartum haemorrage
Primary postpartum haemorrage
 
Postpartum Hemorrhage
Postpartum HemorrhagePostpartum Hemorrhage
Postpartum Hemorrhage
 
Venous Thromboembolism in Obstetrics
Venous Thromboembolism in ObstetricsVenous Thromboembolism in Obstetrics
Venous Thromboembolism in Obstetrics
 
Anaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergenciesAnaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergencies
 
Anaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergenciesAnaesthetic management of obstetric emergencies
Anaesthetic management of obstetric emergencies
 
Pph drill
Pph drillPph drill
Pph drill
 
POSTPARTUM HEMORRHAGE
POSTPARTUM HEMORRHAGEPOSTPARTUM HEMORRHAGE
POSTPARTUM HEMORRHAGE
 
Primary Postpartum Haemorrhage
Primary Postpartum HaemorrhagePrimary Postpartum Haemorrhage
Primary Postpartum Haemorrhage
 
Anaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhageAnaethetic management of obstetric haemorrhage
Anaethetic management of obstetric haemorrhage
 
Pph
PphPph
Pph
 
Anesthetic complications in pregnancy
Anesthetic complications in pregnancyAnesthetic complications in pregnancy
Anesthetic complications in pregnancy
 
L42 Miscarriage & Ectopic
L42 Miscarriage & Ectopic L42 Miscarriage & Ectopic
L42 Miscarriage & Ectopic
 

More from MitikuTeka1

COPD power point presentation for nurse.pptx
COPD power point presentation for nurse.pptxCOPD power point presentation for nurse.pptx
COPD power point presentation for nurse.pptx
MitikuTeka1
 
Atoma Research Methodology presentation .pdf
Atoma Research Methodology presentation .pdfAtoma Research Methodology presentation .pdf
Atoma Research Methodology presentation .pdf
MitikuTeka1
 
3Nonparametric Tests power point presentationpdf
3Nonparametric Tests power point presentationpdf3Nonparametric Tests power point presentationpdf
3Nonparametric Tests power point presentationpdf
MitikuTeka1
 
4Correlational analysis presentation .pdf
4Correlational analysis presentation .pdf4Correlational analysis presentation .pdf
4Correlational analysis presentation .pdf
MitikuTeka1
 
2Analysis of Variance presentation doc.pdf
2Analysis of Variance presentation doc.pdf2Analysis of Variance presentation doc.pdf
2Analysis of Variance presentation doc.pdf
MitikuTeka1
 
6Categorical data analysis presentation.pdf
6Categorical data analysis presentation.pdf6Categorical data analysis presentation.pdf
6Categorical data analysis presentation.pdf
MitikuTeka1
 
5Linear regression presentation note ppdf
5Linear regression presentation note ppdf5Linear regression presentation note ppdf
5Linear regression presentation note ppdf
MitikuTeka1
 
CATARACT disease condition(by Mitiku Teka).pptx
CATARACT disease condition(by Mitiku Teka).pptxCATARACT disease condition(by Mitiku Teka).pptx
CATARACT disease condition(by Mitiku Teka).pptx
MitikuTeka1
 
CATARACT presentation for adult healthpptx
CATARACT presentation for adult healthpptxCATARACT presentation for adult healthpptx
CATARACT presentation for adult healthpptx
MitikuTeka1
 
unit 3 selecting nursing research problem.ppt
unit 3 selecting nursing research problem.pptunit 3 selecting nursing research problem.ppt
unit 3 selecting nursing research problem.ppt
MitikuTeka1
 
unit 9 measurements presentation- short.ppt
unit 9 measurements presentation- short.pptunit 9 measurements presentation- short.ppt
unit 9 measurements presentation- short.ppt
MitikuTeka1
 
Research Literature review present.pptx
Research  Literature review present.pptxResearch  Literature review present.pptx
Research Literature review present.pptx
MitikuTeka1
 
unit 6 types of nursing research approach and design.ppt
unit 6 types of nursing research approach and design.pptunit 6 types of nursing research approach and design.ppt
unit 6 types of nursing research approach and design.ppt
MitikuTeka1
 
unit 8 data collection methods presentation.ppt
unit 8 data collection methods presentation.pptunit 8 data collection methods presentation.ppt
unit 8 data collection methods presentation.ppt
MitikuTeka1
 
unit 2 overview of research processL.ppt
unit 2 overview of research processL.pptunit 2 overview of research processL.ppt
unit 2 overview of research processL.ppt
MitikuTeka1
 
unit 10 Sampling presentation L- short.ppt
unit 10 Sampling presentation L- short.pptunit 10 Sampling presentation L- short.ppt
unit 10 Sampling presentation L- short.ppt
MitikuTeka1
 
CVD PPT Medical Terminology March 2022.pptx
CVD PPT Medical Terminology March 2022.pptxCVD PPT Medical Terminology March 2022.pptx
CVD PPT Medical Terminology March 2022.pptx
MitikuTeka1
 
Epidata presentation course for heath science
Epidata presentation course for heath scienceEpidata presentation course for heath science
Epidata presentation course for heath science
MitikuTeka1
 
COLORECTAL CANCER SEMINAR presentation ppt.
COLORECTAL CANCER SEMINAR presentation ppt.COLORECTAL CANCER SEMINAR presentation ppt.
COLORECTAL CANCER SEMINAR presentation ppt.
MitikuTeka1
 

More from MitikuTeka1 (20)

COPD power point presentation for nurse.pptx
COPD power point presentation for nurse.pptxCOPD power point presentation for nurse.pptx
COPD power point presentation for nurse.pptx
 
Atoma Research Methodology presentation .pdf
Atoma Research Methodology presentation .pdfAtoma Research Methodology presentation .pdf
Atoma Research Methodology presentation .pdf
 
3Nonparametric Tests power point presentationpdf
3Nonparametric Tests power point presentationpdf3Nonparametric Tests power point presentationpdf
3Nonparametric Tests power point presentationpdf
 
4Correlational analysis presentation .pdf
4Correlational analysis presentation .pdf4Correlational analysis presentation .pdf
4Correlational analysis presentation .pdf
 
2Analysis of Variance presentation doc.pdf
2Analysis of Variance presentation doc.pdf2Analysis of Variance presentation doc.pdf
2Analysis of Variance presentation doc.pdf
 
6Categorical data analysis presentation.pdf
6Categorical data analysis presentation.pdf6Categorical data analysis presentation.pdf
6Categorical data analysis presentation.pdf
 
5Linear regressiion analysis power point
5Linear regressiion analysis power point5Linear regressiion analysis power point
5Linear regressiion analysis power point
 
5Linear regression presentation note ppdf
5Linear regression presentation note ppdf5Linear regression presentation note ppdf
5Linear regression presentation note ppdf
 
CATARACT disease condition(by Mitiku Teka).pptx
CATARACT disease condition(by Mitiku Teka).pptxCATARACT disease condition(by Mitiku Teka).pptx
CATARACT disease condition(by Mitiku Teka).pptx
 
CATARACT presentation for adult healthpptx
CATARACT presentation for adult healthpptxCATARACT presentation for adult healthpptx
CATARACT presentation for adult healthpptx
 
unit 3 selecting nursing research problem.ppt
unit 3 selecting nursing research problem.pptunit 3 selecting nursing research problem.ppt
unit 3 selecting nursing research problem.ppt
 
unit 9 measurements presentation- short.ppt
unit 9 measurements presentation- short.pptunit 9 measurements presentation- short.ppt
unit 9 measurements presentation- short.ppt
 
Research Literature review present.pptx
Research  Literature review present.pptxResearch  Literature review present.pptx
Research Literature review present.pptx
 
unit 6 types of nursing research approach and design.ppt
unit 6 types of nursing research approach and design.pptunit 6 types of nursing research approach and design.ppt
unit 6 types of nursing research approach and design.ppt
 
unit 8 data collection methods presentation.ppt
unit 8 data collection methods presentation.pptunit 8 data collection methods presentation.ppt
unit 8 data collection methods presentation.ppt
 
unit 2 overview of research processL.ppt
unit 2 overview of research processL.pptunit 2 overview of research processL.ppt
unit 2 overview of research processL.ppt
 
unit 10 Sampling presentation L- short.ppt
unit 10 Sampling presentation L- short.pptunit 10 Sampling presentation L- short.ppt
unit 10 Sampling presentation L- short.ppt
 
CVD PPT Medical Terminology March 2022.pptx
CVD PPT Medical Terminology March 2022.pptxCVD PPT Medical Terminology March 2022.pptx
CVD PPT Medical Terminology March 2022.pptx
 
Epidata presentation course for heath science
Epidata presentation course for heath scienceEpidata presentation course for heath science
Epidata presentation course for heath science
 
COLORECTAL CANCER SEMINAR presentation ppt.
COLORECTAL CANCER SEMINAR presentation ppt.COLORECTAL CANCER SEMINAR presentation ppt.
COLORECTAL CANCER SEMINAR presentation ppt.
 

Recently uploaded

The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
heathfieldcps1
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
ZurliaSoop
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
AnaAcapella
 

Recently uploaded (20)

SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptxSKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
SKILL OF INTRODUCING THE LESSON MICRO SKILLS.pptx
 
The basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptxThe basics of sentences session 3pptx.pptx
The basics of sentences session 3pptx.pptx
 
Application orientated numerical on hev.ppt
Application orientated numerical on hev.pptApplication orientated numerical on hev.ppt
Application orientated numerical on hev.ppt
 
Towards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptxTowards a code of practice for AI in AT.pptx
Towards a code of practice for AI in AT.pptx
 
Unit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptxUnit-IV; Professional Sales Representative (PSR).pptx
Unit-IV; Professional Sales Representative (PSR).pptx
 
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
Jual Obat Aborsi Hongkong ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan...
 
Dyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptxDyslexia AI Workshop for Slideshare.pptx
Dyslexia AI Workshop for Slideshare.pptx
 
Spellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please PractiseSpellings Wk 3 English CAPS CARES Please Practise
Spellings Wk 3 English CAPS CARES Please Practise
 
Single or Multiple melodic lines structure
Single or Multiple melodic lines structureSingle or Multiple melodic lines structure
Single or Multiple melodic lines structure
 
General Principles of Intellectual Property: Concepts of Intellectual Proper...
General Principles of Intellectual Property: Concepts of Intellectual  Proper...General Principles of Intellectual Property: Concepts of Intellectual  Proper...
General Principles of Intellectual Property: Concepts of Intellectual Proper...
 
This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.This PowerPoint helps students to consider the concept of infinity.
This PowerPoint helps students to consider the concept of infinity.
 
Understanding Accommodations and Modifications
Understanding  Accommodations and ModificationsUnderstanding  Accommodations and Modifications
Understanding Accommodations and Modifications
 
Micro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdfMicro-Scholarship, What it is, How can it help me.pdf
Micro-Scholarship, What it is, How can it help me.pdf
 
Spatium Project Simulation student brief
Spatium Project Simulation student briefSpatium Project Simulation student brief
Spatium Project Simulation student brief
 
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptxBasic Civil Engineering first year Notes- Chapter 4 Building.pptx
Basic Civil Engineering first year Notes- Chapter 4 Building.pptx
 
Introduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The BasicsIntroduction to Nonprofit Accounting: The Basics
Introduction to Nonprofit Accounting: The Basics
 
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
Explore beautiful and ugly buildings. Mathematics helps us create beautiful d...
 
Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024Mehran University Newsletter Vol-X, Issue-I, 2024
Mehran University Newsletter Vol-X, Issue-I, 2024
 
SOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning PresentationSOC 101 Demonstration of Learning Presentation
SOC 101 Demonstration of Learning Presentation
 
ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701ComPTIA Overview | Comptia Security+ Book SY0-701
ComPTIA Overview | Comptia Security+ Book SY0-701
 

1.post portum heamorrghage power pont.pptx

  • 1. POST PARTUM HEMORRHAGE By: Merga Ch. (Msc) 4/27/2024 1
  • 2. Introduction  PPH is an obstetrical emergency that can follow vaginal or cesarean delivery.  It is one of the top five causes of maternal mortality in both high and low per capital income countries  Timely diagnosis, appropriate resources, and appropriate management are critical for preventing death.
  • 3. Definition of PPH 1. PPH is best defined and diagnosed clinically as excessive bleeding that makes the patient symptomatic (e.g. lightheadedness, weakness, palpitations, diaphoresis, restlessness, confusion, air hunger, syncope) and/or results in signs of hypovolemia (e.g. hypotension, tachycardia, oliguria, low oxygen saturation [<95%]) 4/27/2024 3
  • 4. Definition …  2) EBL ≥500 mL after vaginal birth or ≥1000 mL after C/ delivery, or  3) 10 % decline in postpartum Hgb concentration from antepartum levels , or  4) 10 % decline in postpartum maternal blood volume from antepartum levels, and/or  5) Need for blood transfusion following post partum bleeding. 4/27/2024 4
  • 5. Types of PPH 1) Primary PPH ( early PPH) occurs within 24 hours after delivery 2) Secondary PPH (late PPH) occurs 24 hours to 6 weeks after delivery 4/27/2024 5
  • 6. Incidence  The incidence of excessive blood loss following vaginal delivery is 5–8%  Most common cause of excessive blood loss in pregnancy  Most transfusions in pregnant women are performed to replace blood lost after delivery  Leading cause of maternal death  Every pregnant mother is at risk 4/27/2024 6
  • 7. Etiology and risk factors  Bleeding after delivery is controlled by a combination of 1. Contraction of the myometrium, which constricts the blood vessels supplying the placental bed, and 2. local decidual hemostatic factors, including tissue factor , type-1 plasminogen activator inhibitor , and systemic coagulation factors (eg, platelet and circulating clotting factors). 4/27/2024 7
  • 8. Etiology cont….. The 4 Ts of PPH  TONE 70%  TRAUMA 20%  TISSUE 10%  THROMBIN 1% 3.2 4/27/2024 8
  • 9. Etiology cont….. 1)Uterine Atony  Inability of the uterine myometrium to contract effectively.  Is the most common cause of primary PPH (70% )  Complicates 1 in 20 births 4/27/2024 9
  • 10. Risk factors for uterine atony Etiology process Clinical risk factors Over distended uterus Polyhydramnios Multiple gestation Macrosomia Uterine muscle exhaustion Rapid or Prolonged labor High parity Induction/ augmentation Intra-amniotic infection Fever Prolonged ROM Functional/ anatomic distortion of the uterus Fibroid uterus Placenta previa Uterine anomalies others Drugs, GA( halothane), PA, prior History. 4/27/2024 10
  • 11. Etiology cont …..  2) Trauma (genital tract)  Genital tract lacerations are the second leading cause of postpartum hemorrhage.  Trauma related bleeding can be due to;  Lacerations (perineal, vaginal, cervical, uterine),  Incisions ( hysterotomy , episiotomy), Uterine rupture, or Uterine inversion. Risk factors for Genital tract laceration????: 4/27/2024 11
  • 12. Etiology cont…..  3) RPOC( placental tissue and amniotic membranes) can inhibit the uterus from adequate contraction and result in hemorrhage  Risk factors include:  Midtrimester delivery  Chorioamnionitis  Accessory placental lobes  Abnormally adherent placenta  Accreta ….80%  Increta …...15%  Percreta ………..5% • Retained blood clots • Mismanagement of third stage of labor 4/27/2024 12
  • 13. Etiology cont….. 4) Coagulation defects  Acquired and congenital bleeding.  Pre-existing states resulting in coagulation defects includes:  hemophilia A  Acquired causes of coagulopathy include ;  severe preeclampsia and eclampsia,  HELLP syndrome,  Abruption placentae,  Fetal demise (IUFD),  Amniotic fluid embolism (AFE),  Sepsis,  Transfusion of more than 8 U of blood in itself may induce a dilutional coagulopathy.  Consumptive coagulopathy may develop in women with severe hemorrhage. 4/27/2024 13
  • 14. Complications of PPH  Hypovolemic shock and organ failure:  renal failure, stroke, myocardial infarction,  Postpartum hypopituitarism (Sheehan syndrome)  Fluid overload (pulmonary edema, dilutional coagulopathy)  Anemia  Transfusion-related complications  Anesthesia-related complications  Sepsis, wound infection, pneumonia  Venous thrombosis or embolism  Unplanned sterilization due to need for hysterectomy  Asherman syndrome  Death 4/27/2024 14
  • 15. Prevention of PPH  Identify high risk factors for PPH & do proper investigation and preparation,  Iron supplementation during px to build up iron store in high risk women,  Seek and treat anemia in pregnancy  Family planning/child spacing  AMTSL for all delivering mothers.  Spontaneous placental separation during cesarean delivery, and  Prolonged postpartum oxytocin infusion. 4/27/2024 15
  • 16. Prevention cont…  AMTSL- for all laboring mothers  Active management of the third stage of labour prevents PPH by over 60%  Components of AMTSL are; 1. administering uterotonic agent, oxytocin 10 IU IM with in 1 min after delivery 2. Controlled cord traction (CCT), 3. Uterine massage and. 4. Early cord clamping 4/27/2024 16
  • 17. Uterotonic Selection for Prevention of PPH Uterotonic Advantages/Disadvantag es Doses for Preventio n Storage Requirements Oxytocin (IM injection) • Effective 2-3 minutes after injection. • Can only be given intramuscularly. • Can be used in all women. • Reduces length of third stage of labor. • Used ONLY after the delivery of the baby. • Minimal side effects. • Inexpensive. 10 IU • Store between 15C & 25C (59- 77 F). • Delivery room stock may be kept at room temperature— 30C—for up to one year with an expected loss of about 14 percent. • Light does not destabilize oxytocin. 3.3 4/27/2024 17
  • 18. Uterotonic Selection for Prevention of PPH Uterotonic Advantages/Disadvantages Doses for Prevention Storage Requirements Ergometrine (IM Injection) • Effective 6-7 minutes after injection. • Effects may last 2-4 hours. • Inexpensive. • Contraindicated in women with PE, Eclampsia, and high BP. • Can cause nausea and vomiting. • Requires stringent handling and storage conditions. 0.2mg-0.4mg (use local standards as dosage may range from 0.2 mg – 4 mg) • Store between 2°C – 8°C. • Protect from light and freezing. • Requires stringent handling and storage conditions. 3.4 4/27/2024 18
  • 19. Uterotonic Selection for Prevention of PPH Uterotonic Advantages/Disadvantage s Doses for Prevention Storage Requirements Misoprostol (tablet) • Effective 9-12 minutes after ingestion. • Shivering, nausea and elevated temperature. Oral or SL: 600µg Rectal: 800- 1000µg • Store at room temperature in a closed container. 3.5 4/27/2024 19
  • 20. MANAGEMENT Multidisciplinary approach:- Clinicians, OBGYN, Anesthetist, Hematologist, Nurse/Midwives, Laboratory tech… etc 4/27/2024 20
  • 21. Management of PPH 4/27/2024 21  Early recognition of PPH is a very important factor in mgt.  An established plan of action for the management of PPH is of great value when the preventative measures have failed.  Treatment goals  Restore or maintain adequate circulatory volume to prevent hypo perfusion of vital organs  Restore or maintain adequate tissue oxygenation  Reverse or prevent coagulopathy  Eliminate the obstetric cause of PPH
  • 22. GENEERAL MEASURES  SHOUT FOR HELP!!!!!! (Get assistance)  ABCs of life  Oxygenate (intranasal)  Open 2 IV lines (large bore cannula) and resuscitate with crystalloids fast to restore circulatory volume.  Send blood sample to laboratory  Massage uterus and Give oxytocin 10 IU IM  Catheterize and monitor UOP  Evaluate the possible cause of the PPH 4/27/2024 22
  • 23. 4/27/2024 23 Uterine massage uterotonic drugs Bimanual compression and massage Uterine balloon tamponade Surgical management If no response If no response If no response If no response Specific Management : for uterine atony
  • 24. Specific measures…Uterine Atony  Remove clots  Avoid distended bladder  Medical therapy  Oxytocin 20 units in 1000 ml 0f NS Or RL 60 drops/min (>125ml/hr) IV (not more than 3 lit.)  Misoprostol 800-1000 μg PR, SL route allows for lower dosing (400 μg) with higher bioavailability  Methylergometrine 0.2mg can be repeated every 2-4 hr IM or IV ergometrine (maximum 5 doses) 4/27/2024 24
  • 25. Options if medical treatment fails for uterine atony  If bleeding continues:  Explore the uterine cavity  Check placenta again for completeness  Inspect the cervix and the lower genitalia for laceration  If bleeding continues in spite of the above:  Perform bimanual compression of the uterus or compress abdominal aorta until surgical intervention is amenable. 4/27/2024 25
  • 26. Bimanual and Aorta compression 4/27/2024 26
  • 27. Uterine Tamponade 4/27/2024 27  Uterine packing  Transurethral Foley catheter placement and prophylactic antibiotic  A tamponade-balloon  Inserted into the uterus and inflated with 500ml of saline
  • 28. Management cont…  Surgical option include:  B Lynch surgery  Uterine artery ligation  Uterine compression sutures  Hysterectomy 4/27/2024 28
  • 30. Uterine & utero-ovarian artery ligation 4/27/2024 30
  • 31. Management cont… 2) Genital tract laceration -Repair of the tear/laceration -hysterectomy 4/27/2024 31
  • 32. Management cont… 3) RPC  Retained Products of Conceptions  Different methods of removal of RPCs.  Manual removal  Uterine Curettage  Hysterectomy 4/27/2024 32
  • 33. Management cont… 4) Coagulation defects  Lab investigations: platelet count, PT, PTT, fibrinogen level, clotting time  Treatment  Use blood products to control hemorrhage  Give fresh whole blood if available.  Otherwise choose fresh frozen plasma, packed RBC, cryoprecipitate or platelet concetrate based on the major disorder recognized 4/27/2024 33
  • 34. THANK YOU ! 4/27/2024 34